{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:27:56Z","timestamp":1779208076250,"version":"3.51.4"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/cmr.0b013e328322fc20","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T14:02:55Z","timestamp":1242914575000},"page":"63-68","source":"Crossref","is-referenced-by-count":48,"title":["Immunosuppression and melanocyte proliferation"],"prefix":"10.1097","volume":"19","author":[{"given":"Edoardo","family":"Zattra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Belloni","family":"Fortina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Bordignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Piaserico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7696(08)60383-6","article-title":"Genetics, development, and malignancy of melanocytes","volume":"146","author":"Bennett","year":"1993","journal-title":"Int Rev Cytol"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/jidsymp.1997.3","article-title":"Neural stem cells","volume":"2","author":"Murphy","year":"1997","journal-title":"J Investig Dermatol Symp Proc"},{"key":"R3-1-20210129","first-page":"1355","article-title":"Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma","volume":"12","author":"Hau","year":"2004","journal-title":"Oncol Rep"},{"key":"R4-1-20210129","first-page":"480","article-title":"The kit receptor and its ligand, steel factor, as regulators of hemopoiesis","volume":"3","author":"Broxmeyer","year":"1991","journal-title":"Cancer Cell"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0190-9622(95)91274-6","article-title":"Human recombinant stem-cell factor induces melanocytic hyperplasia in susceptible patients","volume":"33","author":"Grichnik","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"R6-1-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ijc.2910520207","article-title":"Progression of human cutaneous melanoma is associated with loss of expression of c-KIT proto-oncogene receptor","volume":"52","author":"Natali","year":"1992","journal-title":"Int J Cancer"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.V80.2.374.374","article-title":"Non-hematopoietic tumor cell lines express stem cell factor and display c-KIT receptors","volume":"80","author":"Turner","year":"1992","journal-title":"Blood"},{"key":"R8-1-20210129","first-page":"283","article-title":"Immunohistochemical localization of stem cell factor (SCF) with comparison of its receptor c-KIT proto-oncogene product (c-kit) in melanocytic tumors","volume":"427","author":"Takahasi","year":"1995","journal-title":"Virchows Arch"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00008390-200008000-00001","article-title":"Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation","volume":"1","author":"Herlyn","year":"2000","journal-title":"Melanoma Res"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.det.2007.04.001","article-title":"The melanocyte and the epidermal melanin unit: an expanded concept","volume":"25","author":"Nordlund","year":"2007","journal-title":"Dermatol Clin"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1600-0749.2000.130103.x","article-title":"The regulation of normal melanocyte proliferation","volume":"13","author":"Halaban","year":"2000","journal-title":"Pigment Cell Res"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0749.2005.00235.x","article-title":"Adhesion, migration and communication in melanocytes and melanoma","volume":"18","author":"Haass","year":"2005","journal-title":"Pigment Cell Res"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.0.CO;2-P","article-title":"Cadherins and tissue formation: integrating adhesion and signaling","volume":"21","author":"Vleminckx","year":"1999","journal-title":"BioEssays"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00008390-199604000-00007","article-title":"E-cadherin expression in human melanoma","volume":"6","author":"Danen","year":"1996","journal-title":"Melanoma Res"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1083\/jcb.153.5.1049","article-title":"E-cadherin suppresses cellular transformation by inhibiting beta-catenin signalling in an adhesion-independent manner","volume":"153","author":"Gottardi","year":"2001","journal-title":"J Cell Biol"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/excr.1999.4577","article-title":"Hepatocyte growth gactor\/scatter factor promotes a switch from E-cadherin to N-cadherin in chick embryo epiblast cells","volume":"251","author":"DeLuca","year":"1999","journal-title":"Exp Cell Res"},{"key":"R17-1-20210129","first-page":"575","article-title":"Endothelin-1 is a paracrine growth factor that modulates melanogenesis of human melanocytes and participates in their responses to ultraviolet radiation","volume":"9","author":"Tada","year":"1998","journal-title":"Cell Growth Differ"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1523-1747.1998.00276.x","article-title":"Rac1 mediates dendrite formation in response to melanocyte stimulating hormone and UV light in murine melanoma model","volume":"111","author":"Scott","year":"1998","journal-title":"J invest Dermatol"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1523-1747.ep12523594","article-title":"Human melanocyte cultured from nevi and melanomas","volume":"87","author":"Halaban","year":"1986","journal-title":"J Invest Dermatol"},{"key":"R20-1-20210129","first-page":"329","article-title":"met and HGF-SF in normal melanocytes and melanoma cells","volume":"65","author":"Halaban","year":"1993","journal-title":"EXS"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02623492","article-title":"bFGF in the putative natural growth factor for human melanocytes","volume":"23","author":"Halaban","year":"1987","journal-title":"In Vitro Cell Dev Biol"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcb.240440403","article-title":"Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes","volume":"44","author":"Bordoni","year":"1990","journal-title":"J Cell Biochem"},{"key":"R23-1-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0923-1811(97)00079-0","article-title":"Growth stimulation of normal melanocytes and nevocellular nevus by gastrin releasing peptide (GRP)","volume":"17","author":"Terashi","year":"1998","journal-title":"J Dermatol Sci"},{"key":"R24-1-20210129","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1043-2760(00)00296-4","article-title":"Alpha-melanocyte-stimulating hormone in normal human physiology and disease states","volume":"11","author":"Catania","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1751-1097.2008.00294.x","article-title":"The melanocortin 1 receptor and the UV response of human melanocytes \u2013 a shift in paradigm","volume":"8","author":"Abdel-Malek","year":"2008","journal-title":"Photochem Photobiol"},{"key":"R26-1-20210129","first-page":"435","article-title":"Long term proliferation of human melanocytes is supported by the physiologic mitogens \u03b1-melanotropin, endothelin-1 and basic fibroblast growth factor","volume":"217","author":"Swope","year":"2000","journal-title":"Exp Cell Res"},{"key":"R27-1-20210129","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.peptides.2005.01.027","article-title":"Alpha-Melanocyte stimulating hormone, inflammation and human melanoma","volume":"27","author":"Eves","year":"2006","journal-title":"Peptides"},{"key":"R28-1-20210129","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"R29-1-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2230.1988.tb00676.x","article-title":"Eruptive dysplastic naevi following renal transplantation","volume":"13","author":"Barker","year":"1988","journal-title":"Clin Exp Dermatol"},{"key":"R30-1-20210129","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0190-9622(96)90661-1","article-title":"Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myalocytic leukaemia: a case report and review of the literature","volume":"35","author":"Richert","year":"1996","journal-title":"Am Acad Dermatol"},{"key":"R31-1-20210129","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archderm.1989.01670150087015","article-title":"Eruptive dysplastic rruptive dysplastic nevi associated with human immunodeficiency virus infection","volume":"125","author":"Duvic","year":"1989","journal-title":"Arch Dermatol"},{"key":"R32-1-20210129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.299.6691.88","article-title":"Excess benign melanocytic nevi in children after chemotherapy for malignancy in childhood","volume":"299","author":"Huges","year":"1989","journal-title":"Br Med J"},{"key":"R33-1-20210129","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/mpo.2950180417","article-title":"Prevalence of naevocytic naevi after chemotherapy for childhood cancer","volume":"18","author":"De Wit","year":"1990","journal-title":"Med Pediatr Oncol"},{"key":"R34-1-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0190-9622(93)70008-H","article-title":"Excess melanocytic nevi in children with renal allografts","volume":"28","author":"Smith","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"R35-1-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2230.1991.tb00325.x","article-title":"The development of excess numbers of melanocytic naevi in an immunosuppressed identical twin","volume":"16","author":"McGregor","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"R36-1-20210129","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2005.06.023","article-title":"Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy","volume":"54","author":"Piaserico","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R37-1-20210129","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0190-9622(03)02482-4","article-title":"Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings","volume":"4","author":"Alaibac","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"R38-1-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008390-200506000-00014","article-title":"Dermoscopic features of eruptive melanocytic naevi in an adult patient receiving immunosuppressive therapy for Crohn's disease","volume":"15","author":"Belloni Fortina","year":"2005","journal-title":"Melanoma Res"},{"key":"R39-1-20210129","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0190-9622(86)70094-7","article-title":"Cyclosporin A","volume":"14","author":"Page","year":"1986","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"R40-1-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07343.x","article-title":"Update on the use of ciclosporin in immune-mediated dermatoses","volume":"155","author":"Griffiths","year":"2006","journal-title":"Br J Dermatol"},{"key":"R41-1-20210129","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.drudis.2006.07.015","article-title":"Disease, destination, dose and delivery aspects of ciclosporin: the state of the art","volume":"11","author":"Italia","year":"2006","journal-title":"Drug Discov Today"},{"key":"R42-1-20210129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/oxfordjournals.ndt.a091879","article-title":"Hyperpigmentation due to cyclosporin therapy","volume":"4","author":"Brady","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"R43-1-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1468-3083.2000.00037.x","article-title":"Bullous acral erythema and concomitant pigmentation on the face and occluded skin","volume":"14","author":"Ozkaya-Bayazit","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R44-1-20210129","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1034\/j.1600-0749.2003.00081.x","article-title":"Effect of cyclosporin A on melanogenesis in cultured human melanocytes","volume":"16","author":"Lee","year":"2003","journal-title":"Pigment Cell Res"},{"key":"R45-1-20210129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.07.059","article-title":"Azathioprine in dermatology: the past, the present, and the future","volume":"55","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R46-1-20210129","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1128\/MCB.19.7.5036","article-title":"Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids","volume":"19","author":"Rogatsky","year":"1999","journal-title":"Mol Cell Biol"},{"key":"R47-1-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1529-8019.2007.00133.x","article-title":"Update on the dermatologic use of systemic glucocorticosteroids","volume":"20","author":"Jackson","year":"2007","journal-title":"Dermatol Ther"},{"key":"R48-1-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1529-8019.2007.00137.x","article-title":"Systemic cyclosporin and tacrolimus in dermatology","volume":"20","author":"Madan","year":"2007","journal-title":"Dermatol Ther"},{"key":"R50-1-20210129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2133.2006.07467.x","article-title":"FK506 increases pigmentation and migration of human melanocytes","volume":"155","author":"Kang","year":"2006","journal-title":"Br J Dermatol"},{"key":"R51-1-20210129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.06739.x","article-title":"FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo","volume":"153","author":"Lan","year":"2005","journal-title":"Br J Dermatol"},{"key":"R52-1-20210129","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2133.2004.06149.x","article-title":"Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug","volume":"151","author":"Fukushima","year":"2004","journal-title":"Br J Dermatol"},{"key":"R53-1-20210129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000063905","article-title":"Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma?","volume":"205","author":"Bogenrieder","year":"2002","journal-title":"Dermatology"},{"key":"R54-1-20210129","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.sder.2005.01.007","article-title":"Overview of biologic agents in medicine and dermatology","volume":"24","author":"Sobell","year":"2005","journal-title":"Semin Cutan Med Surg"},{"key":"R55-1-20210129","first-page":"544","article-title":"Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept","volume":"4","author":"Weinberg","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"R56-1-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jdermsci.2005.01.011","article-title":"Update on the mechanisms and efficacy of biological therapies for psoriasis","volume":"38","author":"Koo","year":"2005","journal-title":"J Dermatol Sci"},{"key":"R57-1-20210129","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1365-2133.2006.07189.x","article-title":"Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals","volume":"154","author":"Bovenschen","year":"2006","journal-title":"Br J Dermatol"},{"key":"R58-1-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00054725-200307000-00013","article-title":"Cutaneous nevi pigmentosus during infliximab therapy in a patient with Crohn's disease: fallacy or coincidence?","volume":"9","author":"Katsanos","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"R59-1-20210129","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0190-9622(93)70218-I","article-title":"Melanocytic activation in HIV-1 disease: HMB-45 staining in common acquired nevi. Military Medical Consortium for the Advancement of Retroviral Research","volume":"29","author":"Smith","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"R60-1-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-4362.1991.tb04645.x","article-title":"Eruptive melanocytic nevi in human immunodeficiency virus infection","volume":"30","author":"Betlloch","year":"1991","journal-title":"Int J Dermatol"},{"key":"R61-1-20210129","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/1523-1747.ep12365586","article-title":"Excess of nevi related to immunodeficiency: a study in HIV-infected patients and renal transplant recipients","volume":"107","author":"Grob","year":"1996","journal-title":"J Invest Dermatol"},{"key":"R62-1-20210129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.cco.0000239886.13537.ed","article-title":"The growing problem of non-AIDS-defining malignancies in HIV","volume":"18","author":"Pantanowitz","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"R63-1-20210129","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1101\/gad.14.14.1712","article-title":"Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage","volume":"15","author":"Goding","year":"2000","journal-title":"Genes Dev"},{"key":"R64-1-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0898-6568(02)00075-X","article-title":"Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signalling modules targets for the anti-inflammatory action of this cytokine?","volume":"15","author":"Haddad","year":"2003","journal-title":"Cell Signal"},{"key":"R65-1-20210129","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.intimp.2006.07.007","article-title":"Effects of immunosuppression on circulating dendritic cells: an adjunct to therapeutic drug monitoring after heart transplantation","volume":"20","author":"Barten","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"R66-1-20210129","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/01.TP.0000163470.83217.E6","article-title":"Association of circulating interleukin (IL)-12 and IL-10-producing dendritic cells with time posttransplant, dose of immunosuppression, and plasma cytokines in renal-transplant recipients","volume":"15","author":"Daniel","year":"2005","journal-title":"Transplantation"},{"key":"R67-1-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing","volume":"16","author":"Edlundh-Rose","year":"2006","journal-title":"Melanoma Res"},{"key":"R68-1-20210129","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1084\/jem.20051848","article-title":"The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells","volume":"203","author":"Sumimoto","year":"2006","journal-title":"J Exp Med"},{"key":"R69-1-20210129","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1600-0749.2004.00164.x","article-title":"The transcription network regulating melanocyte development and melanoma","volume":"17","author":"Vance","year":"2004","journal-title":"Pigment Cell Res"},{"key":"R70-1-20210129","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03269","article-title":"Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression","volume":"17","author":"Carreira","year":"2005","journal-title":"Nature"},{"key":"R71-1-20210129","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.0022-202X.2004.22239.x","article-title":"Solar-simulated ultraviolet radiation-induced upregulation of the melanocortin-1 receptor, proopiomelanocortin, and alpha-melanocyte-stimulating hormone in human epidermis in vivo","volume":"122","author":"Schiller","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"3","key":"R72-1-20210129","doi-asserted-by":"crossref","first-page":"iii52","DOI":"10.1136\/ard.2007.079780","article-title":"Alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs","volume":"66","author":"Luger","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R73-1-20210129","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.4049\/jimmunol.175.7.4806","article-title":"Alpha-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status","volume":"1","author":"Cooper","year":"2005","journal-title":"J Immunol"},{"key":"R74-1-20210129","first-page":"143","article-title":"Modulation of regulatory T cell immunity by the neuropeptide alpha-melanocyte stimulating hormone","volume":"49","author":"Taylor","year":"2003","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R75-1-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14712598.7.3.345","article-title":"Immunotherapy of melanoma: a critical review of current concepts and future strategies","volume":"7","author":"Riker","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"R76-1-20210129","first-page":"994","article-title":"Immunotherapy of advanced or metastatic melanoma","volume":"5","author":"Cebon","year":"2007","journal-title":"Clin Adv Hematol Oncol"},{"key":"R77-1-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1440-0960.2007.00387.x","article-title":"Melanoma in organ transplant recipients: the old enemy finds a new battleground","volume":"48","author":"Dinh","year":"2007","journal-title":"Australasian J Dermatol"},{"key":"R78-1-20210129","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindelof","year":"2000","journal-title":"Br J Dermatol"},{"key":"R79-1-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.125579","article-title":"Skin cancer in organ transplant recipients. Epidemiology, pathogenesis, and management","volume":"47","author":"Berg","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R80-1-20210129","first-page":"1079","article-title":"Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients","volume":"140","author":"Belloni-Fortina","year":"2004","journal-title":"Arch Dermatol"},{"key":"R81-1-20210129","first-page":"459","article-title":"Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants","volume":"137","author":"Otley","year":"2001","journal-title":"Arch Dermatol"},{"key":"R82-1-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force","volume":"20","author":"Taieb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"R83-1-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-0625.2007.00666.x","article-title":"Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?","volume":"17","author":"Schallreuter","year":"2008","journal-title":"Exp Dermatol"},{"key":"R84-1-20210129","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-3083.2007.02228.x","article-title":"Autoimmunity as an aetiological factor in vitiligo","volume":"21","author":"Rezaei","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R85-1-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0065-2776(06)90006-6","article-title":"Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo","volume":"90","author":"Uchi","year":"2006","journal-title":"Adv Immunol"},{"key":"R86-1-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00262-008-0506-5","article-title":"Vaccine-specific local T cell reactivity in immunotherapy-associated vitiligo in melanoma patients","volume":"58","author":"Jacobs","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"R87-1-20210129","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim","year":"1999","journal-title":"Int J Dermatol"},{"key":"R88-1-20210129","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","article-title":"Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases","volume":"51","author":"Silverberg","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R89-1-20210129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-200565040-00002","article-title":"New treatment modalities for vitiligo: focus on topical immunomodulators","volume":"65","author":"Kostovic","year":"2005","journal-title":"Drugs"},{"key":"R90-1-20210129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00008390-200904000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:41:22Z","timestamp":1739119282000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-200904000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0b013e328322fc20","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}